Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(oral rehydration therapy)
105,356 results
  • Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy. [Journal Article]
  • BOBMC Ophthalmol 2019 Jul 19; 19(1):153
  • Gu X, Yu X, Dai H
  • CONCLUSIONS: Three monthly injections of ranibizumab as an initial treatment could significantly improve VA in PCV patients in the short term. At 12 months postinjection, ranibizumab treatment could stabilize VA in most PCV patients. The baseline VA, the reduction in subretinal fluids and the greatest lesion diameter were predictive factors for the relative improvement of VA at the final follow-up.
  • HIV - Old Foe with a New Face. [Journal Article]
  • JAJ Assoc Physicians India 2018; 66(8):93-95
  • Mirgh SP, Mishra VA, … Sorabjee JS
  • We report a case of a middle aged seropositive male, virologically well suppressed on second line ART (Anti-Retroviral therapy) who presented with a subacute history of neurological symptoms. On imag…
  • Biological response to peri-implantitis treatment. [Journal Article]
  • JPJ Periodontal Res 2019 Jul 18
  • Bhavsar I, Miller CS, … Al-Sabbagh M
  • CONCLUSIONS: Elevated concentrations of IL-1β in PICF were consistent with PIP. A decrease in MMP-8 concentration in PICF at three months after treatment is consistent with a healing biological response.
New Search Next